TPCW
TXG icon

TD Private Client Wealth’s 10x Genomics TXG Stock Holding History

TD Private Client Wealth’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8K Hold
47
– – ﹤0.01% 1376
2026
Q1 		$998 Sell
47
-29
-38% -$580 ﹤0.01% 1390
2025
Q4 		$1.24K Sell
76
-72
-49% -$1.09K ﹤0.01% 1336
2025
Q3 		$1.73K Buy
+148
New +$1.93K ﹤0.01% 1259
2022
Q3 		– Sell
-11
Closed -$498 – 1245
2022
Q2 		$498 Buy
+11
New +$571 ﹤0.01% 1202

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TD Private Client Wealth's TXG Position: Q2 2026 in Review

TD Private Client Wealth held its 10x Genomics (TXG) position steady in Q2 2026 at 47 shares worth $1.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1376.

TD Private Client Wealth first reported a position in TXG in Q2 2022 and has held it in 5 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • TD Private Client Wealth held 47 shares of 10x Genomics worth $1.8K as of Q2 2026.
  • TD Private Client Wealth left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #1376 holding.
  • TD Private Client Wealth first reported a position in 10x Genomics in Q2 2022 and has held it in 5 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.